Codexis Inc (CDXS):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C9868)
◆英語タイトル:Codexis Inc (CDXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9868
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:46
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Codexis Inc (Codexis) is a protein engineering company, which develops proteins for a wide range of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, industrial enzymes and fine chemicals, and enzymes as biotherapeutics and for use in molecular diagnostics. The company discovers, identifies, optimizes and produces enzymes by using its technology platforms such as CodeEvolver, protein engineering technology platform, which introduces mutation into genes to transform the enzymes that they produce. It also offers a wide range of biocatalysis solutions ranging from screening and optimization to commercial supply of biocatalysts. The company serves specialist businesses, pharmaceutical, food manufacturing and chemical companies. Codexis is headquartered in Redwood City, California, the US.

Codexis Inc (CDXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Codexis Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Codexis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Codexis Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Codexis Enters into Agreement with Nestle Health Science 10
Codexis Enters into R&D Agreement with Biopharmaceutical Company 12
Purolite Enters Into Co-Development Agreement With Codexis For Immobilized Enzymes 13
Strem Chemicals Enters Into Distribution Agreement With Codexis For Codex Screening Kits 14
Albany Molecular Research Enters Into Smartsourcing Partnership With Codexis 15
Licensing Agreements 16
Porton Pharma Enters into Licensing Agreement with Codexis 16
Merck Enters into Licensing Agreement with Codexis for CodeEvolver Platform Technology 17
Codexis Enters into Licensing Agreement with GlaxoSmithKline for CodeEvolver Protein Engineering Platform 19
Merck Extends Licensing Agreement with Codexis 21
Equity Offering 22
Codexis Prices Public Offering of Shares for USD34.6 Million 22
Codexis Raises USD25.3 Million in Public Offering of Shares 24
Asset Transactions 26
Intrexon Acquires Laboratory Operations From Codexis US$1.5 Million 26
Codexis Inc – Key Competitors 27
Codexis Inc – Key Employees 28
Codexis Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 08, 2018: Codexis reports second quarter 2018 financial results 30
May 10, 2018: Codexis Reports First Quarter 2018 Financial Results 32
Mar 08, 2018: Codexis Reports 2017 Fourth Quarter and Full Year Financial Results 34
Nov 09, 2017: Codexis Reports Financial Results for the Third Quarter of 2017 36
Aug 09, 2017: Codexis Reports Financial Results for the Second Quarter of 2017 38
May 09, 2017: Codexis Reports Financial Results for the First Quarter of 2017 40
Mar 09, 2017: Codexis Reports 2016 Fourth Quarter and Full Year Financial Results 41
Legal and Regulatory 43
Feb 06, 2018: EnzymeWorks Resumes Focus on Biocatalysis 43
Aug 08, 2017: Codexis Obtains Court Order Awarding Summary Judgment of Patent Infringement against EnzymeWorks 44
Product News 45
Jan 06, 2017: Codexis to Offer High-Performance Enzymes for Diagnostics Markets 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Codexis Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Codexis Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Codexis Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Codexis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Codexis Enters into Agreement with Nestle Health Science 10
Codexis Enters into R&D Agreement with Biopharmaceutical Company 12
Purolite Enters Into Co-Development Agreement With Codexis For Immobilized Enzymes 13
Strem Chemicals Enters Into Distribution Agreement With Codexis For Codex Screening Kits 14
Albany Molecular Research Enters Into Smartsourcing Partnership With Codexis 15
Porton Pharma Enters into Licensing Agreement with Codexis 16
Merck Enters into Licensing Agreement with Codexis for CodeEvolver Platform Technology 17
Codexis Enters into Licensing Agreement with GlaxoSmithKline for CodeEvolver Protein Engineering Platform 19
Merck Extends Licensing Agreement with Codexis 21
Codexis Prices Public Offering of Shares for USD34.6 Million 22
Codexis Raises USD25.3 Million in Public Offering of Shares 24
Intrexon Acquires Laboratory Operations From Codexis US$1.5 Million 26
Codexis Inc, Key Competitors 27
Codexis Inc, Key Employees 28
Codexis Inc, Subsidiaries 29

List of Figures
Codexis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Codexis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Codexis Inc (CDXS):製薬・医療:M&Aディール及び事業提携情報(Codexis Inc (CDXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆